adenosine and atl 146e
adenosine has been researched along with atl 146e in 9 studies
Research
Studies (9)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Deflorian, F; Gao, ZG; Jacobson, KA; Katritch, V; Kumar, TS; Phan, K; Stevens, RC; Wu, H; Xu, F | 1 |
| de Lera Ruiz, M; Lim, YH; Zheng, J | 1 |
| Cassada, DC; Fiser, SM; Kaza, AK; Kern, JA; Kron, IL; Linden, J; Long, SM; Rieger, JM; Tribble, CG | 1 |
| Beller, GA; Glover, DK; Linden, J; Macdonald, TL; Petruzella, FD; Rieger, JM; Riou, LM; Ruiz, M; Takehana, K; Watson, DD | 1 |
| Chen, JF; Day, YJ; Fink, JS; Huang, L; Linden, J; McDuffie, MJ; Okusa, MD; Rosin, DL; Schwarzschild, MA; Ye, H | 1 |
| Fang, G; Linden, J; Scheld, WM; Sullivan, GW | 1 |
| Lappas, CM; Linden, J; Rieger, JM | 1 |
| Cerqueira, MD | 1 |
| Kennedy, DP; Lankford, AR; Linden, J; Marshall, MA; Rork, TH; Wallace, KL | 1 |
Reviews
2 review(s) available for adenosine and atl 146e
| Article | Year |
|---|---|
Adenosine A2A receptor as a drug discovery target.
Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction | 2014 |
Advances in pharmacologic agents in imaging: new A2A receptor agonists.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Coronary Vessels; Cyclohexanecarboxylic Acids; Dipyridamole; Heart; Humans; Organotechnetium Compounds; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2006 |
Other Studies
7 other study(ies) available for adenosine and atl 146e
| Article | Year |
|---|---|
Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Amino Acids; Animals; Binding Sites; CHO Cells; Cricetinae; Cricetulus; Crystallography, X-Ray; HEK293 Cells; Humans; Ligands; Models, Molecular; Nucleosides; Phenethylamines; Protein Conformation; Radioligand Assay; Receptor, Adenosine A2A; Stereoisomerism; Structure-Activity Relationship; Thermodynamics | 2012 |
Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashion.
Topics: Adenosine; Animals; Aorta, Thoracic; Cyclohexanecarboxylic Acids; Disease Models, Animal; Drug Administration Schedule; Neurologic Examination; Purinergic P1 Receptor Agonists; Purines; Rabbits; Receptor, Adenosine A2A; Recovery of Function; Reperfusion Injury; Spinal Cord; Surgical Instruments | 2001 |
Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection.
Topics: Adenosine; Animals; Binding, Competitive; Blood Pressure; Cell Line; Coronary Disease; Cyclohexanecarboxylic Acids; Dogs; Dose-Response Relationship, Drug; Heart; Hemodynamics; Humans; Infusions, Intravenous; Myocardium; Purinergic P1 Receptor Agonists; Purines; Radioligand Assay; Radionuclide Imaging; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Recombinant Proteins; Regional Blood Flow; Technetium Tc 99m Sestamibi | 2001 |
Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells.
Topics: Adenosine; Animals; Bone Marrow Cells; Brain; Cell Transplantation; Chemokines; Cyclohexanecarboxylic Acids; Cytokines; Endothelium, Vascular; Genotype; Green Fluorescent Proteins; Kidney; Luminescent Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Purinergic P1 Receptor Agonists; Purines; Receptors, Purinergic P1; Reperfusion Injury; Transplantation Chimera | 2003 |
A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Cyclohexanecarboxylic Acids; Disease Models, Animal; Endotoxemia; Escherichia coli; Escherichia coli Infections; Female; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Purines; Receptors, Adenosine A2; Sepsis; Survival Analysis | 2004 |
A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; CD4-Positive T-Lymphocytes; Cell Line; Cyclic AMP; Cyclohexanecarboxylic Acids; Gene Dosage; Humans; Interferon-gamma; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Purines; Receptor, Adenosine A2A; Receptors, Antigen, T-Cell; RNA, Messenger; Rolipram; Triazines; Triazoles | 2005 |
Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Bone Marrow Transplantation; Cardiovascular Agents; Cell Degranulation; Cells, Cultured; Cyclohexanecarboxylic Acids; Disease Models, Animal; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Perfusion; Phenethylamines; Purines; Receptor, Adenosine A2A; Time Factors; Tryptases; Whole-Body Irradiation | 2008 |